Nanocarriers targeting senescent cells

Ageing and multiple chronic diseases in humans associate with an aberrant accumulation of senescent cells in a diversity of tissues, which contributes to organ dysfunction and drives their pathological manifestations. It emerges that elimination of senescent cells ameliorates and even reverts the pr...

Full description

Bibliographic Details
Main Author: Daniel Muñoz-Espín
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2019-01-01
Series:Translational Medicine of Aging
Online Access:http://www.sciencedirect.com/science/article/pii/S2468501118300075
id doaj-60963e2fd06743e0b6f8c22ca2339444
record_format Article
spelling doaj-60963e2fd06743e0b6f8c22ca23394442021-02-02T07:07:50ZengKeAi Communications Co., Ltd.Translational Medicine of Aging2468-50112019-01-01315Nanocarriers targeting senescent cellsDaniel Muñoz-Espín0CRUK Cambridge Centre Early Detection Programme, Department of Oncology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UKAgeing and multiple chronic diseases in humans associate with an aberrant accumulation of senescent cells in a diversity of tissues, which contributes to organ dysfunction and drives their pathological manifestations. It emerges that elimination of senescent cells ameliorates and even reverts the progression of age-related disorders, thereby extending healthspan and lifespan in preclinical mouse models. Development of delivery carriers specifically targeting senescent cells offers innovative therapeutic and diagnostic applications in translational medicine.http://www.sciencedirect.com/science/article/pii/S2468501118300075
collection DOAJ
language English
format Article
sources DOAJ
author Daniel Muñoz-Espín
spellingShingle Daniel Muñoz-Espín
Nanocarriers targeting senescent cells
Translational Medicine of Aging
author_facet Daniel Muñoz-Espín
author_sort Daniel Muñoz-Espín
title Nanocarriers targeting senescent cells
title_short Nanocarriers targeting senescent cells
title_full Nanocarriers targeting senescent cells
title_fullStr Nanocarriers targeting senescent cells
title_full_unstemmed Nanocarriers targeting senescent cells
title_sort nanocarriers targeting senescent cells
publisher KeAi Communications Co., Ltd.
series Translational Medicine of Aging
issn 2468-5011
publishDate 2019-01-01
description Ageing and multiple chronic diseases in humans associate with an aberrant accumulation of senescent cells in a diversity of tissues, which contributes to organ dysfunction and drives their pathological manifestations. It emerges that elimination of senescent cells ameliorates and even reverts the progression of age-related disorders, thereby extending healthspan and lifespan in preclinical mouse models. Development of delivery carriers specifically targeting senescent cells offers innovative therapeutic and diagnostic applications in translational medicine.
url http://www.sciencedirect.com/science/article/pii/S2468501118300075
work_keys_str_mv AT danielmunozespin nanocarrierstargetingsenescentcells
_version_ 1724299893668839424